Delivery Order SPE2DB25D3012-SPE2DB25FWWNA

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,667.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medical product, with an ultimate completion date of November 4, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,046.76, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $1,470.49 and is a Firm Fixed Price Delivery Order that runs through February 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,736.58 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $16,404.67 and a completion date of September 25, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,614 for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The award was made on October 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,937.21, is a delivery order for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.88, is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price contract type. The contract was not set aside for any specific business category. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.50, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.49, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, to support military healthcare programs. The contract has an ultimate completion date of May 14, 2024 and is structured as a Firm Fixed Price Delivery Order. There is no set-aside designation for this...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWNA
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The award, valued at $2,505.67, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of March 31, 2025 and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/27/25, 12:03 PM